Medication Adherence and Antithrombotic Therapy Outcomes

Background: The AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease) trial demonstrated that rivaroxaban monotherapy has noninferior efficacy and superior safety compared with combination therapy (rivaroxaban plus a single antiplatelet) in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Naoki Chiba, MD, Takashi Noda, MD, PhD, Kotaro Nochioka, MD, PhD, Koichi Kaikita, MD, PhD, Masaharu Akao, MD, PhD, Junya Ako, MD, PhD, Tetsuya Matoba, MD, PhD, Masato Nakamura, MD, PhD, Katsumi Miyauchi, MD, PhD, Nobuhisa Hagiwara, MD, PhD, Kazuo Kimura, MD, PhD, Kunihiko Matsui, MD, MPH, Hisao Ogawa, MD, PhD, Satoshi Yasuda, MD, PhD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-03-01
Col·lecció:	JACC: Asia
Matèries:	atrial fibrillation bleeding coronary artery disease medication adherence monotherapy
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2772374725007045
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!